Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 3 (2006), Issue 2 (February)

1. The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases.
   Proc Natl Acad Sci U S A, 103(5): 1587-92. [Abstract] [Full-text]
2. Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: a diffusion tensor imaging study.
   Am J Psychiatry, 163(2): 322-4. [Abstract] [Full-text]
3. Comorbidity in bipolar disorder among the elderly: results from an epidemiological community sample.
   Am J Psychiatry, 163(2): 319-21. [Abstract] [Full-text]
4. Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study.
   Am J Psychiatry, 163(2): 316-8. [Abstract] [Full-text]
5. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.
   Am J Psychiatry, 163(2): 313-5. [Abstract] [Full-text]
6. Neurocognitive function in unmedicated manic and medicated euthymic pediatric bipolar patients.
   Am J Psychiatry, 163(2): 286-93. [Abstract] [Full-text]
7. Basal ganglia shape alterations in bipolar disorder.
   Am J Psychiatry, 163(2): 276-85. [Abstract] [Full-text]
8. Laboratory-observed behavioral disinhibition in the young offspring of parents with bipolar disorder: a high-risk pilot study.
   Am J Psychiatry, 163(2): 265-71. [Abstract] [Full-text]
9. Risk and resilience markers in bipolar disorder: brain responses to emotional challenge in bipolar patients and their healthy siblings.
   Am J Psychiatry, 163(2): 257-64. [Abstract] [Full-text]
10. Clinical correlates and familial aggregation of age at onset in bipolar disorder.
    Am J Psychiatry, 163(2): 240-6. [Abstract] [Full-text]
11. Clinical features of bipolar depression versus major depressive disorder in large multicenter trials.
    Am J Psychiatry, 163(2): 225-31. [Abstract] [Full-text]
12. Predictors of recurrence in bipolar disorder: primary outcomes from the systematic treatment enhancement program for bipolar disorder (STEP-BD).
    Am J Psychiatry, 163(2): 217-24. [Abstract] [Full-text]
13. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
    Am J Psychiatry, 163(2): 210-6. [Abstract] [Full-text]
14. No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population.
    Neurosci Lett, 395(2): 175-8. [Abstract] [Full-text]
15. Symptomatic and functional outcome of bipolar disorder in Butajira, Ethiopia.
    J Affect Disord, 90(2): 239-49. [Abstract] [Full-text]
16. Emerging treatments for bipolar disorder: safety and adverse effect profiles.
    Ann Pharmacother, 40(2): 276-85. [Abstract] [Full-text]
17. Clinical course of children and adolescents with bipolar spectrum disorders.
    Arch Gen Psychiatry, 63(2): 175-83. [Abstract] [Full-text]
18. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Arch Gen Psychiatry, 63(2): 139-49. [Abstract] [Full-text]
19. Bipolar disorder: historic perspective, current pharmacologic treatment options and a review of quetiapine.
    Expert Rev Neurother, 6(2): 131-44. [Abstract] [Full-text]
20. Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells.
    Life Sci, 78(12): 1317-23. [Abstract] [Full-text]
21. Antidepressant drugs activate SREBP and up-regulate cholesterol and fatty acid biosynthesis in human glial cells.
    Neurosci Lett, 395(3): 185-90. [Abstract] [Full-text]
22. Development of visual motion perception in children of patients with schizophrenia and bipolar disorder: a follow-up study.
    Schizophr Res, 82(1): 9-14. [Abstract] [Full-text]
23. The impact of rheumatoid arthritis on medical expenditures, absenteeism, and short-term disability benefits.
    J Occup Environ Med, 48(2): 135-48. [Abstract] [Full-text]
24. Association Analysis of the GSK-3beta T-50C Gene Polymorphism with Schizophrenia and Bipolar Disorder.
    Neuropsychobiology, 53(1): 51-6. [Abstract] [Full-text]
25. Dopamine Receptor D(1) Gene -48A/G Polymorphism Is Associated with Bipolar Illness but Not with Schizophrenia in a Polish Population.
    Neuropsychobiology, 53(1): 46-50. [Abstract] [Full-text]
26. DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling.
    Hum Mol Genet, 15(5): 743-9. [Abstract] [Full-text]
27. Race--social, biological, or lemonade?
    Am Psychol, 61(2): 176. [Abstract] [Full-text]
28. The interaction between dopamine D2-like and beta-adrenergic receptors in the prefrontal cortex is altered by mood-stabilizing agents.
    J Neurochem, 96(5): 1336-48. [Abstract] [Full-text]
29. Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder.
    Int J Neuropsychopharmacol, 9(2): 209-13. [Abstract] [Full-text]
30. Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock.
    Science, 311(5763): 1002-5. [Abstract] [Full-text]
31. The maudsley family study: premorbid and current general intellectual function levels in familial bipolar I disorder and schizophrenia.
    J Clin Exp Neuropsychol, 28(2): 243-59. [Abstract] [Full-text]
32. The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression.
    BMC Med Genet, 7(1): 10. [Abstract] [Full-text]
33. Monocyte-derived dendritic cells in bipolar disorder.
    Biol Psychiatry, 59(4): 317-26. [Abstract] [Full-text]
34. Influence of postpartum onset on the course of mood disorders.
    BMC Psychiatry, 6: 4. [Abstract] [Full-text]
35. Impaired emotion processing in remitted patients with bipolar disorder.
    J Affect Disord, 91(1): 53-6. [Abstract] [Full-text]
36. Suicide attempts amongst elderly bipolar patients.
    J Affect Disord, 91(1): 91-4. [Abstract] [Full-text]
37. Glial cell number and neuron/glial cell ratios in postmortem brains of bipolar individuals.
    J Affect Disord, 91(1): 87-90. [Abstract] [Full-text]
38. MRI study of corpus callosum in children and adolescents with bipolar disorder.
    Psychiatry Res, 146(1): 83-85. [Abstract] [Full-text]
39. Outpatient visit chaining among patients with serious mental illness.
    Med Care, 44(3): 257-64. [Abstract] [Full-text]
40. Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder.
    Biol Psychiatry, 59(5): 401-7. [Abstract] [Full-text]
41. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia.
    Mol Psychiatry, 11(3): 241-51. [Abstract] [Full-text]
42. Treatment-resistant bipolar disorder.
    Mol Psychiatry, 11(3): 227-40. [Abstract] [Full-text]
43. Extrapyramidal side effects with atypical neuroleptics in bipolar disorder.
    Prog Neuropsychopharmacol Biol Psychiatry, 30(2): 209-13. [Abstract] [Full-text]
44. Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder.
    Mol Psychiatry, 11(3): 252-60. [Abstract] [Full-text]
45. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function.
    Mol Psychiatry, 11(3): 286-300. [Abstract] [Full-text]
46. Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior.
    Pharmacol Biochem Behav. [Abstract] [Full-text]
47. Anticonvulsants in the treatment of bipolar mania.
    Expert Opin Pharmacother, 7(4): 401-10. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.